Page last updated: 2024-08-16

tibolone and medroxyprogesterone acetate

tibolone has been researched along with medroxyprogesterone acetate in 81 studies

Research

Studies (81)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.23)	18.7374
1990's	9 (11.11)	18.2507
2000's	63 (77.78)	29.6817
2010's	8 (9.88)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME	1
Arrighi, B; Benencia, HJ; Berg, G; Halperin, H; Mesch, V; Pilnik, S; Siseles, NO; Wikinski, RW	1
Haverkorn, MJ; Meuwissen, JH; Wiegerinck, MA	1
Gurpide, E; Kloosterboer, HJ; Markiewicz, L; Tang, B	1
Altieri, P; de Aloysio, D; Penacchioni, P; Salgarello, M; Ventura, V	1
Chang, SP; Chen, CR; Tsan, SH; Yang, TS; Yuan, CC	1
Bianchi, S; Fedele, L; Raffaelli, R; Zanconato, G	1
D'Altorio, C; Di Biase, S; Lanzilotti, G; Orsini, G; Pinto, V	1
Al, A; Bukulmez, O; Gurdal, H; Gurgan, T; Ulug, B; Yarali, H	1
Bai, W; Yang, X; Zheng, S	1
Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F	1
Aksu, MF; Elter, K; Erel, CT; Ertungealp, E; Esen, G; Seyisoglu, H; Uras, C	1
Barnes, JF; Farish, E; Hart, DM; Rankin, M	1
Chang, FM; Hsu, CC; Huang, KE; Pan, HA; Wang, ST; Wu, MH	1
Bigler, JM; Burckhardt, P; Landry, M; Pache, T; Renteria, S; Thiébaud, D; Welti, HJ	1
Baracat, EC; Barbosa, IC; Giordano, MG; Haidar, MA; Marinho, RM; Menegocci, JC; Morais, KM; Tomaz, G; Wehba, S	1
Ayar, A; Celik, H; Cikim, G; Kilic, N; Parmaksiz, C; Tug, N	1
Anthony, MS; Clarkson, TB; Gibbs, RB; Nelson, D	1
Anthony, MS; Clarkson, TB; Mikkola, TS; St Clair, RW	1
Chen, CH; Huang, KE; Pai, MC; Pan, HA; Wang, ST; Wu, MH	2
Bots, ML; Dallinga-Thie, GM; Grobbee, DE; Ossewaarde, ME; Rabelink, TJ; van der Schouw, YT; Westerveld, HT	1
Blok, LJ; Burger, CW; De Gooyer, ME; De Ruiter, PE; Gielen, SC; Grootegoed, JA; Hanekamp, EE; Kloosterboer, HJ; Kühne, EC; Smid-Koopman, E	1
Bak, AA; Banga, JD; Bots, ML; de Kleijn, MJ; Grobbee, DE; Ossewaarde, ME; Planellas, J; van der Schouw, YT; Wilmink, HW	1
Dede, M; Goktolga, U; Kuçuk, T; Pabuçcu, R; Yenen, MC	1
Kourtis, A; Kukuvitis, A; Makedos, G; Panidis, D; Papaiconomou, N; Zournatzi, V	1
Ahn, JY; Choi, IS; Han, SH; Jin, DK; Kang, WC; Kim, DS; Kim, HS; Koh, KK; Shin, EK; Yoon, BK	1
Anthony, MS; Clarkson, TB; Rankin, SE; Shadoan, MK; Wagner, JD	1
Ena, G; Rozenberg, S	1
Aedo, S; Duarte, P; Gallardo, E; Porcile, A	1
Campodónico, I; Capetillo, M; Espinoza, A; Lavín, P; Tapia, A; Valdivia, I	1
Augoulea, AD; Christodoulakos, GE; Creatsas, GC; Dendrinos, SG; Lambrinoudaki, IV; Liakakos, T; Panoulis, CP; Rizos, DA	1
Bisanti, T; Capri, O; Cavalieri, AP; De Felice, C; Galoppi, P; Perrone, G; Porfiri, LM	1
Akar, M; Kursun, S; Mendilcioglu, I; Muderrisoglu, H; Simsek, M; Taskin, O	1
Alper, T; Cetinkaya, MB; Kokcu, A; Malatyalioglu, E; Yanik, FF	1
Christodoulakos, GE; Creatsas, GC; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, CA	1
Boerstoel-Streefland, M; Hendricks, PT; Wierik, EJ	1
Atis, A; Aydin, Y; Erdemir, M; Kesim, MD	1
Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V	1
Inan, I; Kelekci, S; Yilmaz, B	1
Bazzocchi, M; Della Martina, M; Driul, L; Fabiani, G; Ianni, A; Marchesoni, D; Zuiani, C	1
Bozdoğan, O; Noyan, V; Sağsöz, N; Yücel, A	1
Carlström, K; Jonasson, AF; Jonsson, B; Odmark, IS	1
Biri, A; Ozcagli, E; Sardas, S	1
Bernardi, F; Casarosa, E; Gabbanini, M; Genazzani, AD; Genazzani, AR; Luisi, M; Palumbo, M; Picciarelli, G; Pieri, M; Pluchino, N	1
Erkaya, S; Uygur, D; Yeşildaglar, N	1
Cline, JM; Conner, P; Register, TC; Skoog, L; Tani, E; von Schoultz, B	1
Kiran, G; Kiran, H	1
Franke, HR; Vermes, I; Werner, HM	1
Bots, ML; Evans, GW; Grobbee, DE; Helmond, FA; McBride, KH; Paskett, ED; Riley, W	1
Gui, QF; Jiang, Y; Jin, MJ; Lin, SQ; Wang, SH	1
Helmond, FA; Landgren, BM; Langer, RD; Rymer, J	1
Edwards, D; Gibbs, RB; Lazar, N; Nelson, D; Talameh, J	1
Avci, R; Develioğlu, O; Kaymaz, C; Uncu, G; Uncu, Y	1
Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Kuhne, EC; Nowzari, D; Ott, MC; Sijmons, B; van der Spek, P; van Ijcken, WF	1
Archer, DF; den Hollander, W; Ferenczy, A; Gallagher, JC; Helmond, FA; Hendrix, S; Rymer, J; Skouby, S; Stathopoulos, V	1
Jespersen, J; Nilas, L; Sidelmann, JJ; Skouby, SO	1
Archer, DF; Mirkin, S	1
Kloosterboer, HJ; Mueck, AO; Seeger, H; Studen, M; Wallwiener, D	1
Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Verheul, HA	1
Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV	1
Diaby, V; Lachaine, J; Perreault, S	1
Bezirtzoglou, E; Konstandi, M; Kotsovolou, O; Papadaki, A; Tsiotsias, A; Voidarou, Ch	1
Biberoglu, K; Celik, HH; Gürsoy, RH; Keskin, PO; Nas, T; Sargon, MF	1
Blok, LJ; Boers-Sijmons, B; Burger, CW; Hanifi-Moghaddam, P; Klaassens, AH; Kloosterboer, HJ; Van der Spek, P; Van Ijcken, WF; van Wijk, FH; Verheul, HA	1
Dedeoğlu, EN; Erenus, M; Yörük, P	1
Christodoulakos, GE; Creatsa, MG; Economou, EV; Kalligerou, I; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Siasou, Z	1
Gram, J; Jespersen, J; Nilas, L; Sidelmann, JJ; Skouby, SO	1
Cline, JM; Haglund, C; Hofling, M; Ma, L; Nordling, S; Sahlin, L; von Schoultz, B	1
Al Kadri, H; Al-Fozan, HM; Hajeer, A; Hassan, S	1
Bots, ML; Dogan, S; Evans, GW; Grobbee, DE; Meijer, R; Plantinga, Y	1
Bevilacqua, E; Brunelli, R; Capri, O; Ceci, F; Ciarla, MV; Galoppi, P; Perrone, G; Strom, R	1
Cetin, A; Cetin, M; Durna, A; Erden, O; Guvenal, F; Guvenal, T	1
Faghihzadeh, S; Moaya, M; Ziaei, S	1
Bots, ML; Evans, GW; Grobbee, DE; Meijer, R; Störk, S	1
Cline, JM; Hirschberg, AL; Hulchiy, M; Sahlin, L; Zhang, H	2
Akercan, F; Akin, M; Akman, L; Duygu, H; Ozerkan, F; Ulukus, M	1
Cunha, EP; Fernandes, CE; Mader, AM; Pinhal, MA; Pompei, LM; Silva, VF; Silveira, ER; Steiner, ML; Theodoro, TR	1
Cunha, EP; Fernandes, CE; Mader, AM; Petri, G; Pinhal, MA; Pompei, LM; Steiner, ML; Theodoro, TR	1
Basar, M; Bozkurt, I; Buchwalder, L; Guzel, E; Kayisli, U; Lockwood, CJ; Ocak, N; Schatz, F	1

Reviews

2 review(s) available for tibolone and medroxyprogesterone acetate

Article	Year
Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study. Human reproduction (Oxford, England), 2003, Volume: 18, Issue:11 Topics: Attitude of Health Personnel; Data Collection; Drug Prescriptions; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gynecology; Humans; Medroxyprogesterone Acetate; Norpregnenes; Physicians; Randomized Controlled Trials as Topic; Women's Health	2003
Hormone therapy for endometriosis and surgical menopause. The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1 Topics: Endometriosis; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause, Premature; Norpregnenes; Pain; Postoperative Complications; Progesterone; Randomized Controlled Trials as Topic; Recurrence	2009

Article

Year

Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study.

Human reproduction (Oxford, England), 2003, Volume: 18, Issue:11

Topics: Attitude of Health Personnel; Data Collection; Drug Prescriptions; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gynecology; Humans; Medroxyprogesterone Acetate; Norpregnenes; Physicians; Randomized Controlled Trials as Topic; Women's Health

2003

Hormone therapy for endometriosis and surgical menopause.

The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1

Topics: Endometriosis; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause, Premature; Norpregnenes; Pain; Postoperative Complications; Progesterone; Randomized Controlled Trials as Topic; Recurrence

2009

Trials

48 trial(s) available for tibolone and medroxyprogesterone acetate

Article	Year
A comparative study of two hormone replacement therapy regimens on safety and efficacy variables. Maturitas, 1995, Volume: 21, Issue:3 Topics: Anabolic Agents; Cervix Uteri; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Vagina	1995
Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT. Maturitas, 1998, Jun-17, Volume: 29, Issue:3 Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Uterine Neoplasms	1998
Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1999, Volume: 62, Issue:5 Topics: Bone Density; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes	1999
Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis. Maturitas, 1999, Aug-16, Volume: 32, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Adult; Anabolic Agents; Endometriosis; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Ovariectomy; Pelvis	1999
[The effects of menopausal replacement therapy in women with uterine myomas]. Minerva ginecologica, 1999, Volume: 51, Issue:11 Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms	1999
Short-term effects of three continuous hormone replacement therapy regimens on platelet tritiated imipramine binding and mood scores: a prospective randomized trial. Fertility and sterility, 2001, Volume: 75, Issue:4 Topics: Affect; Alendronate; Anxiety; Blood Platelets; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Imipramine; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Tritium	2001
A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors. Atherosclerosis, 2002, Volume: 160, Issue:1 Topics: Adult; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Nitrates; Nitrites; Norpregnenes; Oxidation-Reduction; Progesterone Congeners; Risk Factors; Time Factors; Treatment Outcome; Triglycerides; United Kingdom; Women's Health	2002
Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy. Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:4 Topics: Adult; Cholesterol; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Liver Function Tests; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Quality of Life; Sexual Dysfunctions, Psychological; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; Triglycerides	2001
A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone. Climacteric : the journal of the International Menopause Society, 1998, Volume: 1, Issue:3 Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Bone Density; Calcium; Creatinine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur; Horses; Humans; Hydroxyproline; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Lumbar Vertebrae; Medroxyprogesterone Acetate; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal	1998
A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability. Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:1 Topics: Aged; Animals; Coitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Horses; Hot Flashes; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage; Weight Gain	2002
Effects of tibolone on plasma homocysteine levels in postmenopausal women. Fertility and sterility, 2002, Volume: 78, Issue:2 Topics: Androgen Antagonists; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Progesterone Congeners; Prospective Studies	2002
Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy. Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:3 Topics: Blood Flow Velocity; Brain; Carotid Artery, Common; Carotid Artery, Internal; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Circulation; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Middle Cerebral Artery; Norpregnenes; Postmenopause; Prospective Studies; Pulsatile Flow; Single-Blind Method; Treatment Outcome; Triglycerides; Vascular Resistance	2002
Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial. European journal of clinical investigation, 2003, Volume: 33, Issue:5 Topics: Aged; Androgen Antagonists; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Progesterone Congeners; Triglycerides	2003
Does the beneficial effect of HRT on endothelial function depend on lipid changes. Maturitas, 2003, May-30, Volume: 45, Issue:1 Topics: Aged; Blood Pressure; Brachial Artery; Cholesterol; Cholesterol, LDL; Double-Blind Method; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Pulsatile Flow	2003
Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison. The Journal of reproductive medicine, 2003, Volume: 48, Issue:5 Topics: Cognition; Cognition Disorders; Combined Modality Therapy; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Mental Status Schedule; Middle Aged; Norpregnenes; Postmenopause; Progesterone Congeners; Single-Blind Method	2003
Hormone replacement therapy in postmenopausal women with benign fibrocystic mastopathy. Climacteric : the journal of the International Menopause Society, 2003, Volume: 6, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrocystic Breast Disease; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Prospective Studies; Treatment Outcome; Ultrasonography	2003
Differential effects of unopposed versus opposed hormone therapy, tibolone, and raloxifene on substance p levels. Fertility and sterility, 2003, Volume: 80, Issue:1 Topics: Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Progesterone Congeners; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Substance P	2003
Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study. Arteriosclerosis, thrombosis, and vascular biology, 2003, Oct-01, Volume: 23, Issue:10 Topics: Antithrombin III; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cross-Over Studies; Double-Blind Method; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Progesterone; Triglycerides; Vasodilation	2003
[Differential effects on serum IGF-1 of tibolone (5 mg/day) vs combined continuous estrogen/progestagen in post menopausal women]. Revista medica de Chile, 2003, Volume: 131, Issue:10 Topics: Contraceptive Agents, Female; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies	2003
Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women. Fertility and sterility, 2004, Volume: 81, Issue:3 Topics: Biomarkers; Breast; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Immunohistochemistry; Ki-67 Antigen; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Proto-Oncogene Proteins c-bcl-2; Single-Blind Method	2004
Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women. Maturitas, 2004, Jun-15, Volume: 48, Issue:2 Topics: Adult; Body Mass Index; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leptin; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Treatment Outcome	2004
Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac functions in post-menopausal women: a randomized placebo controlled study. Maturitas, 2004, Aug-20, Volume: 48, Issue:4 Topics: Androgen Antagonists; Contraceptive Agents, Female; Double-Blind Method; Echocardiography; Estrogen Replacement Therapy; Female; Heart; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Placebos; Postmenopause; Prospective Studies; Ventricular Function, Left; Ventricular Function, Right	2004
Do lipid profiles of postmenopausal women under oral hormone replacement therapy remain stable or reveal a multiphasic course in time? Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:4 Topics: Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Triglycerides	2004
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:5 Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Greece; Humans; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides	2004
Nitric oxide in postmenopausal women taking three different HRT regimens. Maturitas, 2005, Jan-10, Volume: 50, Issue:1 Topics: Administration, Cutaneous; Contraceptive Agents, Female; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Nitric Oxide; Norpregnenes; Postmenopause; Prospective Studies	2005
Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:2 Topics: Depressive Disorder; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Perimenopause; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2005
Postmenopausal hormone therapy and mammographic breast density. Maturitas, 2006, Jan-10, Volume: 53, Issue:1 Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Single-Blind Method; Treatment Outcome	2006
The effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1 expression in postmenopausal vaginal epithelium. European journal of obstetrics, gynecology, and reproductive biology, 2005, Jul-01, Volume: 121, Issue:1 Topics: Adult; Apoptosis; Biomarkers; Biopsy, Needle; Cyclin D1; Epithelium; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Probability; Prognosis; Reference Values; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Treatment Outcome; Vagina	2005
Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin. Maturitas, 2006, Jan-10, Volume: 53, Issue:1 Topics: Aged; Carbohydrate Metabolism; Enzyme-Linked Immunosorbent Assay; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Regression Analysis; Sex Hormone-Binding Globulin; Sweden	2006
Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:4 Topics: Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Sexual Behavior	2005
Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women. Archives of gynecology and obstetrics, 2006, Volume: 274, Issue:1 Topics: C-Reactive Protein; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies	2006
The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study. European heart journal, 2006, Volume: 27, Issue:6 Topics: Aged; Atherosclerosis; Double-Blind Method; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Treatment Outcome; Tunica Intima; Tunica Media	2006
[Profiles of irregular bleeding induced by low-dose hormone therapy and Chinese formulated herbs products]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2006, Volume: 28, Issue:2 Topics: Adult; Aged; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Metrorrhagia; Middle Aged; Norpregnenes; Phytotherapy; Postmenopause; Risk Assessment	2006
Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study. American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:5 Topics: Aged; Biopsy; Contraceptive Agents, Female; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Ultrasonography; Uterine Hemorrhage	2006
The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:9 Topics: Cataract; Estrogens; Female; Hormone Replacement Therapy; Humans; Intraocular Pressure; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Tears	2006
Endometrial effects of tibolone. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:3 Topics: Aged; Carcinoma; Cohort Studies; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Pain; Uterine Hemorrhage	2007
Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate. Reproductive sciences (Thousand Oaks, Calif.), 2007, Volume: 14, Issue:2 Topics: Aged; Estradiol; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Myometrium; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Tissue Distribution; Uterine Prolapse; Vagina	2007
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:5 Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis	2007
Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vagina. Human reproduction (Oxford, England), 2008, Volume: 23, Issue:2 Topics: Cluster Analysis; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Gene Expression; Gene Expression Profiling; Humans; Medroxyprogesterone Acetate; Myometrium; Norpregnenes; Signal Transduction; Vagina	2008
Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women. Fertility and sterility, 2009, Volume: 91, Issue:2 Topics: Adiposity; Adult; Body Mass Index; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Leptin; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Time Factors; Treatment Outcome; Waist-Hip Ratio; Weight Gain	2009
Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:2 Topics: Adipokines; Adiponectin; Adult; Apoptosis; Atherosclerosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fas Ligand Protein; fas Receptor; Female; Greece; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Resistin; Selective Estrogen Receptor Modulators	2008
The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:6 Topics: Blood Pressure; Body Composition; C-Peptide; Cardiovascular Diseases; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Norpregnenes; Tissue Plasminogen Activator; Treatment Outcome; Triglycerides	2008
Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of the OPAL study. Current medical research and opinion, 2009, Volume: 25, Issue:1 Topics: Carotid Arteries; Double-Blind Method; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Norpregnenes; Placebos; Reproducibility of Results; Tunica Intima; Ultrasonography	2009
Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause. Gynecologic and obstetric investigation, 2009, Volume: 68, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Analysis of Variance; Blood Coagulation Factors; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Factor VII; Female; Fibrinolysis; Follow-Up Studies; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies	2009
Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions. Advances in therapy, 2009, Volume: 26, Issue:8 Topics: Adult; Analysis of Variance; Blood Flow Velocity; Cerebrovascular Circulation; Chi-Square Distribution; Cognition; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Mental Status Schedule; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Turkey; Ultrasonography, Doppler, Transcranial	2009
Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:3 Topics: Androgen Antagonists; Body Composition; Body Constitution; Calcium, Dietary; Contraceptive Agents, Female; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Vitamin D; Vitamins	2010
Striking increases in carotid artery wall thickness in healthy subjects. Cerebrovascular diseases (Basel, Switzerland), 2010, Volume: 30, Issue:5 Topics: Carotid Arteries; Carotid Artery Diseases; Estrogens; Female; Follow-Up Studies; Hemorrhage; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Nonlinear Dynamics; Norpregnenes; Postmenopause; Time Factors; Tunica Intima; Tunica Media; Ultrasonography	2010
The effects of different hormone treatment on endothelial function in healthy postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:9 Topics: Adult; Brachial Artery; Drug Combinations; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Health; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Ultrasonography; Vasodilation	2013

Other Studies

31 other study(ies) available for tibolone and medroxyprogesterone acetate

Article	Year
Quantitative relationships between steroid structure and binding to putative progesterone receptors. Journal of medicinal chemistry, 1977, Volume: 20, Issue:9 Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship	1977
Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy. Maturitas, 1995, Volume: 21, Issue:2 Topics: Adult; Aged; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progestins; Uterine Hemorrhage	1995
Human endometrial 3 beta-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14). The Journal of steroid biochemistry and molecular biology, 1993, Volume: 45, Issue:5 Topics: 3-Hydroxysteroid Dehydrogenases; Adult; Blotting, Western; Endometrium; Estrogens; Female; Humans; In Vitro Techniques; Kinetics; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Progestins; Spectrophotometry	1993
[Effect of conjugated estrogen and Org OD14 on serum lipoprotein and apolipoprotein in perimenopausal and postmenopausal women]. Zhonghua fu chan ke za zhi, 1999, Volume: 34, Issue:5 Topics: Adult; Aged; Apolipoproteins; Apolipoproteins E; Cholesterol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Premenopause	1999
Mammographic density changes during different postmenopausal hormone replacement therapies. Fertility and sterility, 2001, Volume: 76, Issue:3 Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors	2001
Mammographic density increase in women receiving different hormone replacement regimens. Maturitas, 2001, Nov-30, Volume: 40, Issue:2 Topics: Adult; Breast; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Retrospective Studies	2001
Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomologus monkeys. Neuroscience, 2002, Volume: 113, Issue:4 Topics: Acetylcholinesterase; Animals; Brain; Choline O-Acetyltransferase; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy	2002
Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys. Stroke, 2002, Volume: 33, Issue:11 Topics: Animals; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Cholesterol, HDL; Cholesterol, VLDL; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Lipoproteins, LDL; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Postmenopause; Time; Vascular Patency	2002
Progestogenic effects of tibolone on human endometrial cancer cells. The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:5 Topics: Cell Division; Endometrial Neoplasms; Female; Fibronectins; Gene Expression Regulation; Humans; Insulin-Like Growth Factor Binding Protein 3; Medroxyprogesterone Acetate; Norpregnenes; Progesterone; Progestins; Receptors, Progesterone; Tumor Cells, Cultured	2003
Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys. Metabolism: clinical and experimental, 2003, Volume: 52, Issue:9 Topics: Animals; Arteriosclerosis; Blood Glucose; Body Composition; Body Weight; C-Peptide; Carbohydrates; Dietary Fats; Energy Intake; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Fructosamine; Insulin; Insulin Resistance; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Postmenopause	2003
[Effects of hormonal replacement therapy on breast density in postmenopausal women]. Minerva ginecologica, 2004, Volume: 56, Issue:2 Topics: Breast; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Time Factors	2004
Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study. Climacteric : the journal of the International Menopause Society, 2004, Volume: 7, Issue:2 Topics: Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Norpregnenes; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; United Kingdom	2004
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Maturitas, 2005, Apr-11, Volume: 50, Issue:4 Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone	2005
Assessment of DNA damage in postmenopausal women under hormone replacement therapy. Maturitas, 2005, Jul-16, Volume: 51, Issue:3 Topics: Case-Control Studies; Comet Assay; DNA; DNA Damage; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Risk Factors; Surveys and Questionnaires	2005
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:3 Topics: Administration, Cutaneous; Adrenal Glands; Aging; Dehydroepiandrosterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydrocortisone; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Ovariectomy; Postmenopause; Pregnanolone; Progesterone; Progestins	2005
Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys. American journal of obstetrics and gynecology, 2005, Volume: 193, Issue:1 Topics: Animals; Apoptosis; Biomarkers; Caspase 3; Caspases; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; Drug Administration Schedule; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Immunohistochemistry; Macaca fascicularis; Mammary Glands, Animal; Medroxyprogesterone Acetate; Norpregnenes; Tumor Suppressor Protein p53	2005
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured	2005
Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys. Journal of neuroendocrinology, 2006, Volume: 18, Issue:9 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Dopamine; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Hormones; Hydroxyindoleacetic Acid; Macaca fascicularis; Medroxyprogesterone Acetate; Menopause; Norepinephrine; Norpregnenes; Ovariectomy; Serotonin	2006
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line. Journal of molecular endocrinology, 2006, Volume: 37, Issue:3 Topics: Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Estrogens; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norpregnenes; Oligonucleotide Array Sequence Analysis; Progesterone; Transcription, Genetic	2006
A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability. Human reproduction (Oxford, England), 2007, Volume: 22, Issue:4 Topics: Aged; Animals; Blood Coagulation; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hemostasis; Horses; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Thromboembolism; Venous Thrombosis	2007
Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium. Maturitas, 2007, Aug-20, Volume: 57, Issue:4 Topics: Adenocarcinoma; Angiopoietin-1; Cell Line, Tumor; Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Receptor Modulators; Female; Humans; Medroxyprogesterone Acetate; Norpregnenes; Receptor, TIE-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Necrosis Factor-alpha	2007
In vitro effects of tibolone and its metabolites on human vascular coronary cells. Maturitas, 2007, Sep-20, Volume: 58, Issue:1 Topics: Biomarkers; Cells, Cultured; Coronary Vessels; E-Selectin; Endothelins; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Epoprostenol; Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 1; Medroxyprogesterone Acetate; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Norethindrone; Norpregnenes; Plasminogen Activator Inhibitor 1; Vascular Resistance	2007
Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women. Maturitas, 2007, Oct-20, Volume: 58, Issue:2 Topics: Canada; Cost-Benefit Analysis; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Markov Chains; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Quality-Adjusted Life Years	2007
Hormone therapy alters the composition of the vaginal microflora in ovariectomized rats. Microbial ecology, 2008, Volume: 55, Issue:4 Topics: Animals; Bacteria; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrus; Ethinyl Estradiol; Female; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Rats; Rats, Wistar; Vagina; Vaginosis, Bacterial	2008
Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users. Saudi medical journal, 2007, Volume: 28, Issue:12 Topics: Aged; Case-Control Studies; Endometrium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Tamoxifen	2007
Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeys. Climacteric : the journal of the International Menopause Society, 2009, Volume: 12, Issue:1 Topics: Animals; Estrogens, Conjugated (USP); Female; Immunohistochemistry; Macaca fascicularis; Mammary Glands, Animal; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Receptors, Androgen; Syndecan-1	2009
Effects of long-term tibolone treatment on nuclear sex steroid hormone receptors and G-protein-coupled estrogen receptor-1 expression in the macaque uterus. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:3 Topics: Animals; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Macaca; Medroxyprogesterone Acetate; Norpregnenes; Ovariectomy; Receptors, Steroid; Syndecan-1; Uterus	2012
Receptors for thyrotropin-releasing hormone, thyroid-stimulating hormone, and thyroid hormones in the macaque uterus: effects of long-term sex hormone treatment. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:11 Topics: Animals; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Immunohistochemistry; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Receptors, Thyroid Hormone; Receptors, Thyrotropin; Receptors, Thyrotropin-Releasing Hormone; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Uterus	2012
Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone? Climacteric : the journal of the International Menopause Society, 2015, Volume: 18, Issue:4 Topics: Animals; Biomarkers; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Extracellular Matrix; Female; Glucuronidase; Heparan Sulfate Proteoglycans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction	2015
Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis. Climacteric : the journal of the International Menopause Society, 2015, Volume: 18, Issue:4 Topics: Animals; Apoptosis; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Random Allocation; Rats; Rats, Wistar	2015
Effects of tibolone and its metabolites on prolactin and insulin-like growth factor binding protein-1 expression in human endometrial stromal cells. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2015, Volume: 31, Issue:5 Topics: Blotting, Western; Contraceptive Agents, Female; Dexamethasone; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrenes; Estrogen Receptor Modulators; Estrogens; Female; Furans; Glucocorticoids; Hormone Antagonists; Humans; Insulin-Like Growth Factor Binding Protein 1; Medroxyprogesterone Acetate; Mifepristone; Norpregnanes; Norpregnenes; Prolactin; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stromal Cells	2015